News and History
-
GSK to invest $30 billion in R&D and Manufacturing in the U.S. over next 5 years
Read More: GSK to invest $30 billion in R&D and Manufacturing in the U.S. over next 5 yearsOn Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
-
Lilly announces plans to build $5 billion manufacturing facility in Virginia
Read More: Lilly announces plans to build $5 billion manufacturing facility in VirginiaOn Sept. 16, 2025, Eli Lilly announced that it plans to build a $5 billion manufacturing facility just…
-
Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease
Read More: Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney DiseaseOn Sept. 15, 2025, Corstasis Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved ENBUMYST™…
-
Ebola vaccination begins in the Democratic Republic of the Congo
Read More: Ebola vaccination begins in the Democratic Republic of the CongoOn Sept. 14, 2025, the World Health Organization announced that vaccination of frontline health workers and contacts of…
-
Corn diseases lurk in bumper US crop, threatening yields
Read More: Corn diseases lurk in bumper US crop, threatening yieldsOn Sept. 12, 2025, high levels of fungal disease are lurking in corn fields across the U.S. Midwest,…
-
Melinda French Gates launches $100 million push for women’s health research
Read More: Melinda French Gates launches $100 million push for women’s health researchOn Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
-
Merck to scrap London drug research centre
Read More: Merck to scrap London drug research centreOn Sept. 10, 2025, Merck announced it was scrapping research operations in London, citing the UK’s challenging business…
-
The tale of the creature with the most chromosomes
Read More: The tale of the creature with the most chromosomesOn Sept. 19, 2025, researchers at the Wellcome Sanger Institute and the Institute of Evolutionary Biology, Barcelona reported…
-
Utah Health Officials Report Large Measles Exposure
Read More: Utah Health Officials Report Large Measles ExposureOn Sept. 10, 2025, the Utah Department of Health and Human Services (UDOH) reported a potential large exposure…
-
UK trial launches to transform Alzheimer’s diagnosis with simple blood test
Read More: UK trial launches to transform Alzheimer’s diagnosis with simple blood testOn Sept. 10, 2025, a major University of London (UCL)-led clinical trial, aiming to transform the diagnosis of…
-
NASA’s Mars Rover Discovered Potential Biosignature
Read More: NASA’s Mars Rover Discovered Potential BiosignatureOn Sept. 10, 2025, the National Aeronautics and Space Administration (NASA) announced that a sample collected by NASA’s…
-
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
Read More: Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood TestOn Sept. 10, 2025, Exact Sciences announced the launch of the Cancerguard™ test, a new multi-cancer early detection…
-
Novartis to acquire Tourmaline Bio and pipeline for atherosclerotic cardiovascular disease, valued at $1.4 Billion
Read More: Novartis to acquire Tourmaline Bio and pipeline for atherosclerotic cardiovascular disease, valued at $1.4 BillionOn Sept. 9, 2025, Novartis announced that it has entered into an agreement to acquire Tourmaline Bio, a…
-
Emergent BioSolutions Receives New Contract for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
Read More: Emergent BioSolutions Receives New Contract for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. GovernmentOn Sept. 9, 2025, Emergent BioSolutions announced that a contract modification has been executed in the amount of…
-
Lilly launches TuneLab platform to give biotech companies access to AI-enabled drug discovery models with over $1 billion in research investment
Read More: Lilly launches TuneLab platform to give biotech companies access to AI-enabled drug discovery models with over $1 billion in research investmentOn Sept. 9, 2025, Eli Lilly announced the launch of Lilly TuneLab, an artificial intelligence and machine learning…
-
Elutia Announces Sale of BioEnvelope Business to Boston Scientific for $88 Million
Read More: Elutia Announces Sale of BioEnvelope Business to Boston Scientific for $88 MillionOn Sept. 9, 2025, Elutia announced it has entered into a definitive agreement to sell its EluPro™ and…
-
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
Read More: Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 FormulaOn Sept. 8, 2025, Pfizer and BioNTech announced positive topline results from an ongoing Phase 3 clinical trial…
-
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
Read More: Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New ZealandOn Sept. 8, 2025, Femasys announced it has received approval from the New Zealand Medicines and Medical Devices…
-
Nearly half of people with diabetes don’t realize they have the disease
Read More: Nearly half of people with diabetes don’t realize they have the diseaseOn Sept. 8, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
-
Study Led by Roswell Park Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes
Read More: Study Led by Roswell Park Finds GLP-1 Receptor Agonists Improve Lung Cancer OutcomesOn Sept. 8, 2025, research led by Sai Yendamuri, MD, MBA, FACS, Chair of Thoracic Surgery at Roswell…
